Abstract

Best wishes in 2025 to our Thyroid journal family! This year, 2025, marks the 35th anniversary of our journal.
On this occasion, I would like to share a special tribute to the authors who have shaped our journal. Thank you for contributing your important work and sharing it with the Thyroid community through our journal. Your contributions have advanced our scientific understanding and clinical care in the field of Thyroidology. Through the years, there have been many landmark papers published in our journal. However, I will focus here on several notable papers published in Thyroid late 2023 to 2024. There is not sufficient space to discuss all of the excellent papers that were published in our journal in the past year, but I will highlight a few of those that were of highest interest to other citing authors and our readers.
First of all, I would like to congratulate Dr. Miyauchi and his team at Kuma Hospital in Japan for the highest-cited original research article published in our journal in 2023/2024, entitled “Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.” 1 I also congratulate Dr. Maria Cabanillas and the entire thyroid cancer team at the University of Texas MD Anderson Cancer Center for the top-cited thyroid cancer article published in our journal in 2024, entitled “Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.” 2 The top downloaded paper from 2024 was a systematic review entitled “Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.” 3 The top cited basic science original article published in Thyroid in 2024 was from the team of Dr. Jens Mittag in Germany, entitled, “Hypothalamic Thyroid Hormone Receptor α1 Signaling Controls Body Temperature.” 4 There are many more important papers that I unfortunately do not have space to mention them all here.
I would like to take this opportunity to thank the associate editors at Thyroid (Drs. Sheue-yann Cheng, Leonidas Duntas, Cosimo Durante, Melanie Goldfarb, Haixia Guan, Megan Haymart, Joachim Pohlenz, Douglas Ross, and Mark Zafereo), our social media editor—Dr. Avital Harari, our Editor-in-Chief Emeritus—Peter Kopp, our dedicated editorial board members, our reviewers (who are named in the December 2024 issue), the American Thyroid Association staff in our editorial office (Ms. Claudia Crail-Muñoz and Ms. Sharleene Cano), as well as the Peer Review Operations team at Mary Ann Liebert, Inc. and the production team at KnowledgeWorks Global, Ltd.
I would like to pay special tribute to two highly active, long-standing editorial board members on the Thyroid team who passed away in 2024, including Dr. Virgina Livolsi and Dr. Irwin Klein. In Memoriam articles dedicated to these two champions in our field are available at https://www.liebertpub.com/doi/10.1089/thy.2024.0306 and https://www.liebertpub.com/doi/10.1089/thy.2024.11142.mem, respectively. I am personally very thankful for having the opportunity to work with Drs. Livolsi and Klein. I and the entire Thyroid team dearly miss Drs. Livolsi and Klen and we will always remember them both as remarkable individuals who made tremendous contributions to the field of Thyroidology and our journal, Thyroid. May they rest in peace.
I would also like to celebrate the past and ongoing contributions of some of our most productive editorial board members. First, I would like to congratulate Dr. Guisseppe Barbesino on receiving the honor of the editorial board member of the year! Over the years, Dr. Barbesino has contributed hundreds of reviews to our journal, and his insightful reviews have been much appreciated by editors and authors. Some additional highly productive editorial board members who consistently provided excellent reviews over the past year (in alphabetical order) who I would like to acknowledge include: Drs. Trevor Angell, Martin Biermann, Giorgio Grani, Jacqueline Jonklaas, Won Gu Kim, Cari M. Kitahara, Spiridoula Maraka, Mary Samuels, Alvaro Sanabria, and Franklin Tessler. One of our longstanding editorial board members, Dr. Don Mcleod, will be starting his new role as an associate editor of Thyroid in February, 2025, and I welcome him to that position. I would also like to express my appreciation to some outgoing members of our editorial board. I thank Dr. Megan Haymart for her many years of dedicated work as an associate editor of Thyroid, as she is completing her term. Special thanks as well to Drs. Tania Ortiga-Carvalho, Richard Payne, Arthur Schneider, and David Taïeb, who also completed their service on the Editorial Board.
Finally, I would like to thank you, the readers of Thyroid! Thank you for your support, your feedback, and for continuing to engage in our journal. We thank you for your role in advancing global knowledge in thyroidology and for implementing this knowledge in improving the clinical care of your patients, as well as educating others on the foundational scientific understanding of the thyroid and its related diseases. Happy Anniversary to our global Thyroid community!
Footnotes
Acknowledgments
Special thanks to Ms. Jamie Devereaux from Mary Ann Liebert, Inc. for the Thyroid citation and download data.
Authors’ Contributions
This editorial was conceptualized, written, edited, and approved by A.M.S.
Author Disclosures Statement
A.M.S. is the editor-in-chief of Thyroid.
Funding Information
No funding was received for this article.
